Zealand Pharma Unveils Metabolic Frontier 2030 Strategy
11 Dec 2025 //
GLOBENEWSWIRE
Boehringer`s Survodutide Cut Fibrosis, No MASH Worsening In 64.5%
07 Jun 2024 //
GLOBENEWSWIRE
Zealand: Boehringer`s Survodutide Cut Fibrosis, No MASH Worsening
07 Jun 2024 //
GLOBENEWSWIRE
Zealand: Boehringer To Present Positive Survodutide MASH Trial At EASL
06 Jun 2024 //
GLOBENEWSWIRE
Obesity drug from Boehringer, Zealand succeeds in MASH trial
27 Feb 2024 //
BIOPHARMA DIVE

Market Place
Sourcing Support